The World Anti-Doping Agency (WADA) has appealed against the verdict of Italy’s young tennis star, Jannik Sinner. The 23-year-old is already
regarded as one of the best players currently playing in men’s tennis in the
singles category, along with the likes of Spain’s Carlos Alcaraz and Serbia’s
Novak Djokovic.
Sinner has been in the news for the wrong reasons recently. The reigning world number one managed to narrowly escape a ban after testing positive for the banned substance clostebol in two doping tests. The International Tennis
Integrity Agency (ITIA), in a detailed statement, announced that they accepted
the player’s counsel’s response where they claimed that the availability of the
banned substance in minimal quantity in the player’s sample was because of
receiving a cream from a member of the coaching staff to treat an injury.
That decision received widespread criticism from certain
quarters in the tennis community, including some current and former players,
who called for similar treatment for other players who have tested positive for banned substances in the past. Things are about to get a little tougher for the Italian tennis star as WADA has decided to appeal against the
verdict in the Court of Arbitration for Sport (CAS).
In a statement that was issued by the organisation on their official website, WADA has demanded a one or two-year suspension for Sinner and claimed that ITIA’s verdict, which found the player with ‘no fault or negligence’, was not correct. However, WADA made it clear that they are not seeking the
disqualification of any result, which would mean that Sinner’s triumph at the US
Open, where he defeated America’s Taylor Fritz in the final in straight sets
with a score of 6-3, 6-4, 7-5, will remain intact.
“The World Anti-Doping Agency (WADA) confirms that on
Thursday 26 September, it lodged an appeal to the Court of Arbitration for
Sport (CAS) in the case of Italian tennis player, Jannik Sinner, who was found
by an independent tribunal of the International Tennis Integrity Agency (ITIA)
to bear no fault or negligence having twice tested positive for clostebol, a
prohibited substance, in March 2024,” said the statement. “It is WADA’s view
that the finding of “no fault or negligence” was not correct under the
applicable rules. WADA is seeking a period of ineligibility of between one and
two years. WADA is not seeking a disqualification of any results, save that
which has already been imposed by the tribunal of first instance.”
Azeem Siddiqui is a seasoned sports journalist and data analyst with a strong background in both digital media and live sports production.
He began his journalism career working with partners of The New York Times and has since contributed to several leading international sports publications, including Fox Sports Asia, Calciomercato, and GiveMeSport. Since 2023, Azeem has been part of the TennisUpToDate team, where he has played a key role in sustaining the platform’s growth and ensuring tennis fans receive timely and reliable coverage of the sport’s biggest stories.
In addition to his editorial work, Azeem has extensive experience as a data analyst in live sports broadcasting—particularly in cricket—where he combines analytical precision with creative storytelling. He has collaborated with multiple production companies and cricket boards worldwide, delivering real-time insights and data-driven narratives during live match coverage.